14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $1.14 $1.40 Friday, 3rd May 2024 ACRS stock ended at $1.36. This is 3.82% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 6.87% from a day low at $1.31 to a day high of $1.40.
90 days $1.05 $1.51
52 weeks $0.590 $11.12

Historical Aclaris Therapeutics prices

Date Open High Low Close Volume
Jan 18, 2023 $17.97 $18.24 $17.18 $17.23 326 200
Jan 17, 2023 $17.89 $18.13 $17.32 $17.90 823 200
Jan 13, 2023 $17.54 $18.48 $17.54 $17.95 432 907
Jan 12, 2023 $16.54 $17.72 $16.34 $17.63 232 200
Jan 11, 2023 $17.27 $17.43 $16.20 $16.54 209 000
Jan 10, 2023 $16.31 $17.32 $16.31 $17.25 214 723
Jan 09, 2023 $16.71 $16.76 $16.22 $16.31 218 249
Jan 06, 2023 $15.34 $16.64 $15.21 $16.55 327 500
Jan 05, 2023 $14.77 $15.56 $14.65 $15.23 284 080
Jan 04, 2023 $15.24 $15.30 $14.65 $14.97 265 948
Jan 03, 2023 $15.93 $16.53 $14.89 $15.07 348 167
Dec 30, 2022 $16.13 $16.58 $15.72 $15.75 326 150
Dec 29, 2022 $15.63 $16.40 $15.15 $16.13 178 986
Dec 28, 2022 $15.11 $15.67 $14.99 $15.49 256 199
Dec 27, 2022 $15.12 $15.65 $14.98 $15.03 178 273
Dec 23, 2022 $15.30 $15.34 $14.91 $15.08 288 756
Dec 22, 2022 $14.98 $15.36 $14.86 $15.29 332 711
Dec 21, 2022 $15.12 $15.48 $14.87 $15.00 260 740
Dec 20, 2022 $14.56 $15.24 $14.47 $15.04 254 720
Dec 19, 2022 $15.45 $15.45 $14.02 $14.60 395 295
Dec 16, 2022 $15.50 $15.93 $15.05 $15.59 665 219
Dec 15, 2022 $15.96 $16.19 $15.55 $15.65 251 910
Dec 14, 2022 $16.33 $16.92 $15.94 $16.17 469 892
Dec 13, 2022 $15.99 $16.29 $15.80 $15.94 323 982
Dec 12, 2022 $15.22 $16.02 $15.18 $15.59 363 922
Click to get the best stock tips daily for free!

About Aclaris Therapeutics

Aclaris Therapeutics Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant unmet needs for immuno-inflammatory diseases. The Contract Research segment engages in the provision of... ACRS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT